Literature DB >> 8621150

Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes.

P Ginès1, X Li, S E Brown, T Nakamura, P S Guzelian, L E Heasley, R W Schrier, R A Nemenoff.   

Abstract

Increased intracellular cyclic adenosine monophosphate (cAMP) levels have been shown in some reports to inhibit and in other studies to stimulate growth factor-mediated activation of the mitogen-activated protein kinase (MAP kinase) pathway, depending on the cell type examined. The relationship between cAMP and MAP kinase in hepatocytes has not been examined. In the current study, stimulation of primary cultures of rat hepatocytes with hepatocyte growth factor (HGF) or epidermal growth factor (EGF) increased Ras, Raf, and MAP kinase activity. Incubation of hepatocytes with cAMP-increasing agents blocked activation of Raf by both HGF and EGF, whereas activation of Ras was unaffected. MAP kinase activation by HGF was completely inhibited, whereas EGF-stimulated MAP kinase activity was only slightly reduced. Incubation of hepatocytes with pertussis toxin slightly blunted MAP kinase activation by EGF but not HGF. Increasing cAMP in hepatocytes preincubated with pertussis toxin completely inhibited the activation of MAP kinase by EGF. In conclusion, HGF activates MAP kinase in hepatocytes exclusively through an Raf-dependent pathway and this activation may be completely blocked by increasing cAMP. In contrast, EGF activates MAP kinase in hepatocytes through both Raf-dependent and Raf-independent pathways: the latter pathway probably involves a pertussis toxin-sensitive G protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621150     DOI: 10.1002/hep.510230535

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes.

Authors:  H Talarmin; C Rescan; S Cariou; D Glaise; G Zanninelli; M Bilodeau; P Loyer; C Guguen-Guillouzo; G Baffet
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins.

Authors:  Y V Fedorov; N C Jones; B B Olwin
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.

Authors:  Bernhard Svejda; Mark Kidd; Andrew Timberlake; Kathy Harry; Alexander Kazberouk; Simon Schimmack; Ben Lawrence; Roswitha Pfragner; Irvin M Modlin
Journal:  Cancer Sci       Date:  2013-05-24       Impact factor: 6.716

4.  Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations.

Authors:  C Rescan; A Coutant; H Talarmin; N Theret; D Glaise; C Guguen-Guillouzo; G Baffet
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

5.  Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver.

Authors:  A K Kurz; C Block; D Graf; S V Dahl; F Schliess; D Häussinger
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

6.  Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes.

Authors:  O Melien; T Christoffersen; M Sioud
Journal:  BMC Cell Biol       Date:  2001-07-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.